Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Arkansas Best Corporation (NASDAQ: ABFS) shares surged 16.18 percent to close at $22.90 a share Friday. The stock traded between $20.00 and $23.74 on volume of 1.87 million shares traded. The company reported revenues were $576.9 million for the second quarter of 2013, an increase of 13 percent when compared to a year ago. Shares of Arkansas Best have gained approximately 140.0 percent year-to-date.
Get more information on Arkansas Best and free access to the in-depth equity report at:
Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) shares declined 4.28 percent to close at $15.44 a share Friday. The stock traded between $15.20 and $15.73 on volume of 7.09 million shares traded. The company reported revenues were $344.8 million for the second quarter of 2013, a decrease of 7.0 percent when compared to a year ago. Shares of Allscripts Healthcare Solutions have gained approximately 64.0 percent year-to-date.
Get more information on Allscripts and free access to the in-depth equity report at:
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) shares declined 5.96 percent to close at $69.08 a share Friday. The stock traded between $67.06 and $72.06 on volume of 2.49 million shares traded. The company reported a profit of $0.76 a share for the second quarter of 2013, which $0.05 short of the analysts’ consensus estimate, according to Thomson Reuters. Shares of Salix Pharmaceuticals have gained approximately 70.0 percent year-to-date.
Get more information on Salix Pharmaceuticals and free access to the in-depth equity report at:
Wright Medical Group Inc. (NASDAQ: WMGI) shares fell 8.11 percent to close at $24.86 a share Friday. The stock traded between $24.00 and $25.18 on volume of 2.54 million shares traded. The company announced it has received a not approvable letter from the FDA in response to its Pre-Market Approval application for Augment Bone Graft. Shares of Wright Medical Group have gained approximately 18.0 percent year-to-date.
Get more information on Wright Medical Group and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...